ZTS
Zoetis Inc
NYSE: ZTS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$114.97
+1.00% today
Updated 2026-04-30
Market cap
$48.05B
P/E ratio
18.91
P/S ratio
5.08x
EPS (TTM)
$6.02
Dividend yield
1.71%
52W range
$113 – $170
Volume
3.8M
Zoetis Inc (ZTS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
28.20%
Operating margin
34.70%
ROE
66.00%
ROA
15.30%
Debt/equity
2.85x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | $2.76B | $-100.00M | 61.67% | 10.18% | -3.62% |
| 2010 | $3.58B | $110.00M | 58.21% | 8.63% | 3.07% |
| 2011 | $4.23B | $245.00M | 59.96% | 16.16% | 5.79% |
| 2012 | $4.34B | $436.00M | 62.71% | 19.70% | 10.06% |
| 2013 | $4.56B | $504.00M | 62.11% | 18.00% | 11.05% |
| 2014 | $4.79B | $583.00M | 62.86% | 20.27% | 12.18% |
| 2015 | $4.76B | $339.00M | 62.27% | 22.71% | 7.11% |
| 2016 | $4.89B | $821.00M | 64.30% | 28.72% | 16.80% |
| 2017 | $5.31B | $864.00M | 64.88% | 32.54% | 16.28% |
| 2018 | $5.83B | $1.43B | 65.18% | 32.29% | 24.52% |
| 2019 | $6.26B | $1.50B | 65.70% | 32.24% | 23.96% |
| 2020 | $6.67B | $1.64B | 66.79% | 33.99% | 24.54% |
| 2021 | $7.78B | $2.04B | 68.31% | 36.05% | 26.20% |
| 2022 | $8.08B | $2.11B | 67.77% | 36.24% | 26.16% |
| 2023 | $8.54B | $2.34B | 68.28% | 35.92% | 27.43% |
| 2024 | $9.26B | $2.49B | 69.10% | 36.65% | 26.86% |
| 2025 | $9.47B | $2.67B | 70.49% | 38.00% | 28.23% |